AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Nov 20, 2017

30071_dirs_2017-11-20_8baddda5-85e7-4300-bfee-cb84771a4c58.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-16

Reporting Person: Drexler Karen (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	2991	Direct

Footnotes

F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2018, or the annual shareholder's meeting in the year following the grant date.